Anxiety, Depression, and Quality of Life After Procedural Intervention for Uterine Fibroids
- 1 March 2022
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Women's Health
- Vol. 31 (3), 415-424
- https://doi.org/10.1089/jwh.2020.8915
Abstract
Background: Quality of life (QOL) and psychological health has been reported to be decreased among women with gynecological conditions such as uterine fibroids (UFs). Materials and Methods: Women enrolled in the Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry, receiving procedural therapy for symptomatic UFs, were eligible for this analysis if they completed a series of health-related QOL surveys administered at three time points (baseline, 6–12 weeks postprocedure, and 1 year postprocedure; n = 1486). Ethical approval for this study was obtained at each recruiting site and the coordinating center (NCT02260752, clinicaltrials.gov). Results: More than 26% (n = 393) of women reported moderate anxiety/depression on the baseline anxiety/depression domain of the Euro-QOL 5-dimension instrument. At both the 6–12 weeks and 1-year postprocedural follow-up, there was significant improvement in the UF QOL symptom severity score (p < 0.001, p < 0.001), the total UF symptom QOL score (p < 0.001, p < 0.001), and the Euro-QOL 5-dimension visual analog scale (p < 0.001, p = 0.004) compared with the preprocedural baseline scores. The reporting of anxiety/depression decreased by 66.4% among women who were at baseline, whereas 5.6% of women previously reporting no anxiety/depression reported anxiety/depression at the 1-year follow-up. Conclusion: UF symptoms were more severe among women reporting anxiety/depression at baseline. At the 1-year follow-up, health-related QOL scores improved among all women and the prevalence of anxiety/depression decreased in most, but not all women, whereas severity of anxiety/depression worsened in a small percentage of women (5.6%). Overall, these results suggest that UF treatment improves symptoms of anxiety/depression associated with symptomatic UFs.Keywords
This publication has 40 references indexed in Scilit:
- Measuring quality of life in mental health: Are we asking the right questions?Social Science & Medicine (1982), 2014
- A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measuresHealth Technology Assessment, 2014
- The impact of uterine leiomyomas: a national survey of affected womenAmerican Journal of Obstetrics and Gynecology, 2013
- Uterine LeiomyomasObstetrics & Gynecology, 2011
- The effect of myomectomy on health‐related quality of life of women with myoma uteriJournal of Obstetrics and Gynaecology Research, 2010
- Polycystic ovary syndrome and risk of uterine leiomyomataFertility and Sterility, 2007
- Self-reported heavy bleeding associated with uterine leiomyomataObstetrics & Gynecology, 2003
- The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomataObstetrics & Gynecology, 2002
- The Maine Womenʼs Health StudyObstetrics & Gynecology, 1994
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990